ANDLAUER HEALTHCARE GROUP IN (AND.CA) Stock Earnings & Estimates
Canada - TSX:AND - CA0342231077 - Common Stock
52.17 CAD
-0.53 (-1.01%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 648.423M 47.33% | 647.952M -0.07% | 650.477M 0.39% | 661.53M 1.70% | 686.17M 3.72% | 702.03M 2.31% | |
| EBITDA YoY % growth | 174.797M 50.14% | 164.202M -6.06% | 164.897M 0.42% | 165.18M 0.17% | 179.59M 8.72% | 186.2M 3.68% | |
| EBIT YoY % growth | 110.345M 49.72% | 96.053M -12.95% | 93.963M -2.18% | 92.767M -1.27% | 105.63M 13.87% | 115.46M 9.31% | |
| Operating Margin | 17.02% | 14.82% | 14.45% | 14.02% | 15.39% | 16.45% | |
| EPS YoY % growth | 1.78 -19.09% | 1.56 -12.36% | 1.58 1.28% | 1.70 7.39% | 1.93 13.84% | 2.06 6.41% |
All data in CAD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.42 1.62% | 0.46 4.83% | 0.45 21.47% | 0.42 24.76% | 0.51 21.21% | 0.55 19.34% | 0.46 3.37% | 0.48 14.29% | 0.49 -2.00% | 0.51 -8.26% |
| Revenue Q2Q % growth | 165.25M 3.54% | 172.51M 2.51% | 172.79M 4.04% | 170.01M 8.56% | 175.89M 6.44% | 181.85M 5.41% | 179.21M 3.72% | 180.21M 6.00% | 181.17M 3.00% | 183.19M 0.74% |
| EBITDA Q2Q % growth | 42.417M -45.00% | 44.876M -54.05% | 43.612M 10.40% | 42.149M -23.10% | 45.7M 7.74% | 48.563M 8.22% | 45.45M 4.21% | 46.46M 10.23% | 47.47M 3.87% | 48.48M -0.17% |
| EBIT Q2Q % growth | 24.049M 1.02% | 26.33M -1.53% | 24.618M 14.15% | 20.622M 9.24% | 27.972M 16.31% | 32.421M 23.13% | N/A | N/A | N/A | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.34 -10.53% | 0.42 | -0.08 | -19.85% |
| Q1 2025 Q2Q % growth | 0.37 5.71% | 0.41 | -0.04 | -10.65% |
| Q4 2024 Q2Q % growth | 0.44 | 0.46 | -0.02 | -5.29% |
| Q3 2024 Q2Q % growth | 0.41 13.89% | 0.41 | 0.00 | -0.99% |
| Q2 2024 Q2Q % growth | 0.38 2.70% | 0.40 | -0.02 | -5.94% |
| Q1 2024 Q2Q % growth | 0.35 -10.26% | 0.44 | -0.09 | -21.24% |
| Q4 2023 Q2Q % growth | 0.44 -4.35% | 0.42 | 0.02 | 3.72% |
| Q3 2023 Q2Q % growth | 0.36 -18.18% | 0.40 | -0.04 | -10.52% |
| Q2 2023 Q2Q % growth | 0.37 -24.49% | 0.42 | -0.05 | -11.57% |
| Q1 2023 Q2Q % growth | 0.39 | 0.42 | -0.03 | -8.06% |
| Q4 2022 Q2Q % growth | 0.46 -63.49% | 0.43 | 0.03 | 7.93% |
| Q3 2022 Q2Q % growth | 0.44 41.94% | 0.42 | 0.02 | 5.61% |
| Q2 2022 Q2Q % growth | 0.49 48.48% | 0.37 | 0.12 | 31.12% |
| Q1 2022 Q2Q % growth | 0.39 30.00% | 0.42 | -0.03 | -6.95% |
| Q4 2021 Q2Q % growth | 1.26 250.00% | 0.37 | 0.89 | 244.62% |
| Q3 2021 Q2Q % growth | 0.31 40.91% | 0.34 | -0.03 | -8.10% |
| Q2 2021 Q2Q % growth | 0.33 83.33% | 0.33 | 0.00 | 0.53% |
| Q1 2021 Q2Q % growth | 0.30 36.36% | 0.26 | 0.04 | 15.13% |
| Q4 2020 Q2Q % growth | 0.36 89.47% | 0.26 | 0.10 | 39.78% |
| Q3 2020 Q2Q % growth | 0.22 | 0.21 | 0.01 | 3.72% |
| Q2 2020 Q2Q % growth | 0.18 | 0.20 | -0.02 | -8.14% |
| Q1 2020 Q2Q % growth | 0.22 | 0.20 | 0.02 | 12.67% |
| Q4 2019 Q2Q % growth | 0.19 | 0.54 | -0.35 | -64.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 156.602M -3.00% | 168.84M | -12.238M | -7.25% |
| Q1 2025 Q2Q % growth | 166.088M 3.07% | 169.25M | -3.162M | -1.87% |
| Q4 2024 Q2Q % growth | 168.293M -0.46% | 171.94M | -3.647M | -2.12% |
| Q3 2024 Q2Q % growth | 159.6M 1.82% | 164.77M | -5.17M | -3.14% |
| Q2 2024 Q2Q % growth | 161.446M 2.60% | 164.69M | -3.244M | -1.97% |
| Q1 2024 Q2Q % growth | 161.138M -2.21% | 170.66M | -9.522M | -5.58% |
| Q4 2023 Q2Q % growth | 169.067M 1.99% | 167.11M | 1.957M | 1.17% |
| Q3 2023 Q2Q % growth | 156.754M -4.94% | 164.27M | -7.516M | -4.58% |
| Q2 2023 Q2Q % growth | 157.357M -7.11% | 168.52M | -11.163M | -6.62% |
| Q1 2023 Q2Q % growth | 164.774M 11.07% | 162.02M | 2.754M | 1.70% |
| Q4 2022 Q2Q % growth | 165.772M 24.62% | 159.33M | 6.442M | 4.04% |
| Q3 2022 Q2Q % growth | 164.898M 58.25% | 160.17M | 4.728M | 2.95% |
| Q2 2022 Q2Q % growth | 169.402M 58.13% | 147.71M | 21.692M | 14.69% |
| Q1 2022 Q2Q % growth | 148.351M 54.90% | 138M | 10.351M | 7.50% |
| Q4 2021 Q2Q % growth | 133.025M 53.56% | 121.75M | 11.275M | 9.26% |
| Q3 2021 Q2Q % growth | 104.199M 37.45% | 107.44M | -3.241M | -3.02% |
| Q2 2021 Q2Q % growth | 107.125M 52.49% | 105.89M | 1.235M | 1.17% |
| Q1 2021 Q2Q % growth | 95.77M 17.29% | 93.592M | 2.178M | 2.33% |
| Q4 2020 Q2Q % growth | 86.63M 15.97% | 88.892M | -2.262M | -2.54% |
| Q3 2020 Q2Q % growth | 75.81M 6.71% | 79.323M | -3.513M | -4.43% |
| Q2 2020 Q2Q % growth | 70.25M -1.26% | 74.212M | -3.962M | -5.34% |
| Q1 2020 Q2Q % growth | 81.65M 14.36% | 76.168M | 5.482M | 7.20% |
| Q4 2019 Q2Q % growth | 74.7M | 77.032M | -2.332M | -3.03% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -7.3% | 0% | -5.26% |
| Revenue | 0% | -3.2% | 0% | -3.54% |